STI Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

STI has a total shareholder equity of ₩243.5B and total debt of ₩894.6M, which brings its debt-to-equity ratio to 0.4%. Its total assets and total liabilities are ₩317.7B and ₩74.1B respectively. STI's EBIT is ₩19.6B making its interest coverage ratio -213.9. It has cash and short-term investments of ₩78.0B.

Anahtar bilgiler

0.4%

Borç/özkaynak oranı

₩894.58m

Borç

Faiz karşılama oranı-213.9x
Nakit₩78.02b
Eşitlik₩243.54b
Toplam yükümlülükler₩74.14b
Toplam varlıklar₩317.68b

Son finansal sağlık güncellemeleri

Recent updates

With A 29% Price Drop For STI Co., Ltd. (KOSDAQ:039440) You'll Still Get What You Pay For

Sep 19
With A 29% Price Drop For STI Co., Ltd. (KOSDAQ:039440) You'll Still Get What You Pay For

At ₩20,650, Is STI Co., Ltd. (KOSDAQ:039440) Worth Looking At Closely?

Sep 04
At ₩20,650, Is STI Co., Ltd. (KOSDAQ:039440) Worth Looking At Closely?

STI Co., Ltd. (KOSDAQ:039440) Stocks Pounded By 27% But Not Lagging Market On Growth Or Pricing

Jul 25
STI Co., Ltd. (KOSDAQ:039440) Stocks Pounded By 27% But Not Lagging Market On Growth Or Pricing

Is It Too Late To Consider Buying STI Co., Ltd. (KOSDAQ:039440)?

May 21
Is It Too Late To Consider Buying STI Co., Ltd. (KOSDAQ:039440)?

Estimating The Intrinsic Value Of STI Co., Ltd. (KOSDAQ:039440)

Apr 16
Estimating The Intrinsic Value Of STI Co., Ltd. (KOSDAQ:039440)

STI's (KOSDAQ:039440) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Mar 28
STI's (KOSDAQ:039440) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Why Investors Shouldn't Be Surprised By STI Co., Ltd.'s (KOSDAQ:039440) 27% Share Price Surge

Feb 26
Why Investors Shouldn't Be Surprised By STI Co., Ltd.'s (KOSDAQ:039440) 27% Share Price Surge

Does STI (KOSDAQ:039440) Have A Healthy Balance Sheet?

May 03
Does STI (KOSDAQ:039440) Have A Healthy Balance Sheet?

Is STI Co., Ltd. (KOSDAQ:039440) An Attractive Dividend Stock?

Apr 14
Is STI Co., Ltd. (KOSDAQ:039440) An Attractive Dividend Stock?

Are STI Co., Ltd. (KOSDAQ:039440) Investors Paying Above The Intrinsic Value?

Apr 01
Are STI Co., Ltd. (KOSDAQ:039440) Investors Paying Above The Intrinsic Value?

What Is STI Co., Ltd.'s (KOSDAQ:039440) Share Price Doing?

Mar 19
What Is STI Co., Ltd.'s (KOSDAQ:039440) Share Price Doing?

Should You Be Impressed By STI's (KOSDAQ:039440) Returns on Capital?

Mar 04
Should You Be Impressed By STI's (KOSDAQ:039440) Returns on Capital?

STI (KOSDAQ:039440) Has Gifted Shareholders With A Fantastic 178% Total Return On Their Investment

Feb 17
STI (KOSDAQ:039440) Has Gifted Shareholders With A Fantastic 178% Total Return On Their Investment

Here's Why STI (KOSDAQ:039440) Has A Meaningful Debt Burden

Feb 02
Here's Why STI (KOSDAQ:039440) Has A Meaningful Debt Burden

Is STI Co., Ltd.'s (KOSDAQ:039440) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Jan 18
Is STI Co., Ltd.'s (KOSDAQ:039440) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Read This Before Buying STI Co., Ltd. (KOSDAQ:039440) For Its Dividend

Jan 03
Read This Before Buying STI Co., Ltd. (KOSDAQ:039440) For Its Dividend

Is There Now An Opportunity In STI Co., Ltd. (KOSDAQ:039440)?

Dec 10
Is There Now An Opportunity In STI Co., Ltd. (KOSDAQ:039440)?

Should We Be Excited About The Trends Of Returns At STI (KOSDAQ:039440)?

Nov 25
Should We Be Excited About The Trends Of Returns At STI (KOSDAQ:039440)?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: A039440's short term assets (₩211.3B) exceed its short term liabilities (₩72.9B).

Uzun Vadeli Yükümlülükler: A039440's short term assets (₩211.3B) exceed its long term liabilities (₩1.3B).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: A039440 has more cash than its total debt.

Borcun Azaltılması: A039440's debt to equity ratio has reduced from 10.7% to 0.4% over the past 5 years.

Borç Kapsamı: A039440's debt is well covered by operating cash flow (1606.7%).

Faiz Kapsamı: A039440 earns more interest than it pays, so coverage of interest payments is not a concern.


Bilanço


Sağlıklı şirketleri keşfedin